The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A Nonsense Mutation of the Sodium Channel Gene SCN2A in a Patient with Intractable Epilepsy and Mental Decline
Open accessAbstract
Mutations, exclusively missense, of voltage-gated sodium channel α subunit type 1 (SCN1A) and type 2 (SCN2A) genes were reported in patients with idiopathic epilepsy: generalized epilepsy with febrile seizures plus. Nonsense and frameshift mutations of SCN1A, by contrast, were identified in intractable epilepsy: severe myoclonic epilepsy in infancy (SMEI). Here we describe a first nonsense mutation of SCN2A in a patient with intractable epilepsy and severe mental decline. The phenotype is similar to SMEI but distinct because of partial epilepsy, delayed onset (1 year 7 months), and absence of temperature sensitivity. A mutational analysis revealed that the patient had a heterozygous de novo nonsense mutation R102X of SCN2A. Patch-clamp analysis of Na v 1.2 wild-type channels and the R102X mutant protein coexpressed in human embryonic kidney 293 cells showed that the truncated mutant protein shifted the voltage dependence of inactivation of wild-type channels in the hyperpolarizing direction. Analysis of the subcellular localization of R102X truncated protein suggested that its dominant negative effect could arise from direct or indirect cytoskeletal interactions of the mutant protein. Haploinsufficiency of Na v 1.2 protein is one plausible explanation for the pathology of this patient; however, our biophysical findings suggest that the R102X truncated protein exerts a dominant negative effect leading to the patient's intractable epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The second strongest overall association, with two truncating mutations in ASD cases and three such mutations in ID cases, is SCN2A, a gene previously associated with epilepsy and seizure disorders [52,53].”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
Ionic channels of excitable membranes
(1985) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(85)90172-7 · Cited by 7,134
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292
Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2
Escayg, A., MacDonald, B. T., Meisler, M. H., Baulac, S., Huberfeld, G., An-Gourfinkel, I., Brice, A., LeGuern, E., Moulard, B., Chaigne, D., et al. (2000) · Nature Genetics · doi:10.1038/74159 · Cited by 996
Wallace, R. H., Wang, D. W., Singh, R., Scheffer, I. E., George, A. L., Phillips, H. A., Saar, K., Reis, A., Johnson, E. W., Sutherland, G. R., et al. (1998) · Nature Genetics · doi:10.1038/1252 · Cited by 996
(2005) · Cited by 944
Hentze, M. W., & Kulozik, A. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80542-5 · Cited by 809
Mutant GABAA receptor γ2-subunit in childhood absence epilepsy and febrile seizures
Wallace, R. H., Marini, C., Petrou, S., Harkin, L. A., Bowser, D. N., Panchal, R. G., Williams, D. A., Sutherland, G. R., Mulley, J. C., Scheffer, I. E., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-49 · Cited by 780
First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene
Baulac, S., Huberfeld, G., Gourfinkel‐An, I., Mitropoulou, G., Beranger, A., Prud’homme, J.-F., Baulac, M., Brice, A., Bruzzone, R., & Leguern, É. (2001) · Nature Genetics · doi:10.1038/ng0501-46 · Cited by 765
Scheffer, I. E. (1997) · Brain · doi:10.1093/brain/120.3.479 · Cited by 758
Research works printed but not linked: 3
- 1978, Vie Med, 8, 543
- 1997, Am J Physiol, 273, H1832
- 1995, Am J Physiol, 269, H203
Cited by
Sorted by citations
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
De novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514
Molecular Physiology of Cardiac Repolarization
Nerbonne, J. M., & Kass, R. S. (2005) · Physiological Reviews · doi:10.1152/physrev.00002.2005 · Cited by 1,104
Rauch, A., Wieczorek, D., Graf, E., Wieland, T., Endele, S., Schwarzmayr, T., Albrecht, B., Bartholdi, D., Beygo, J., Di Donato, N., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61480-9 · Cited by 1,041
Ogiwara, I., Miyamoto, H., Morita, N., Atapour, N., Mazaki, E., Inoue, I., Takeuchi, T., Itohara, S., Yanagawa, Y., Obata, K., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5270-06.2007 · Cited by 879
Self-citationTargeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2646 · Cited by 687
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2
Strauss, K. A., Puffenberger, E. G., Huentelman, M. J., Gottlieb, S., Dobrin, S. E., Parod, J. M., Stephan, D. A., & Morton, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052773 · Cited by 630
Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders
Wolff, M., Johannesen, K. M., Hedrich, U. B. S., Masnada, S., Rubboli, G., Gardella, E., Lesca, G., Ville, D., Milh, M., Villard, L., et al. (2017) · Brain · doi:10.1093/brain/awx054 · Cited by 600
Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction
Goldberg, E. M., & Coulter, D. A. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3482 · Cited by 542
Sodium channel mutations in epilepsy and other neurological disorders
Meisler, M. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25466 · Cited by 512
Clinical application of exome sequencing in undiagnosed genetic conditions
Need, A. C., Shashi, V., Hitomi, Y., Schoch, K., Shianna, K. V., McDonald, M., Meisler, M. H., & Goldstein, D. B. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-100819 · Cited by 438
A de novo convergence of autism genetics and molecular neuroscience
Krumm, N., O’Roak, B. J., Shendure, J., & Eichler, E. E. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.11.005 · Cited by 423
Sodium channel SCN1A and epilepsy: Mutations and mechanisms
Escayg, A., & Goldin, A. L. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02640.x · Cited by 410
Mulley, J. C., Scheffer, I. E., Petrou, S., Dibbens, L. M., Berkovic, S. F., & Harkin, L. A. (2005) · Human Mutation · doi:10.1002/humu.20178 · Cited by 351
Berkovic, S. F., Harkin, L. A., McMahon, J. M., Pelekanos, J. T., Zuberi, S. M., Wirrell, E. C., Gill, D. S., Iona, X., Mulley, J. C., & Scheffer, I. E. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70446-x · Cited by 295
Ben-Shalom, R., Keeshen, C. M., Berrios, K. N., An, J. Y., Sanders, S. J., & Bender, K. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.01.009 · Cited by 288
Navigating the channels and beyond: unravelling the genetics of the epilepsies
Helbig, I., Scheffer, I. E., Mulley, J. C., & Berkovic, S. F. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70039-5 · Cited by 281
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures
Howell, K. B., McMahon, J. M., Carvill, G. L., Tambunan, D., Mackay, M. T., Rodriguez-Casero, V., Webster, R., Clark, D., Freeman, J. L., Calvert, S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001926 · Cited by 255
Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology
Catarino, C. B., Liu, J. Y. W., Liagkouras, I., Gibbons, V. S., Labrum, R. W., Ellis, R., Woodward, C., Davis, M. B., Smith, S. J., Cross, J. H., et al. (2011) · Brain · doi:10.1093/brain/awr129 · Cited by 227
Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects
Meisler, M. H., O’Brien, J. E., & Sharkey, L. M. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.188482 · Cited by 215
Mechanisms of human inherited epilepsies
Reid, C. A., Berkovic, S. F., & Petrou, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.016 · Cited by 207
De novo mutations of voltage-gated sodium channel α II gene SCN2A in intractable epilepsies
Ogiwara, I., Ito, K., Sawaishi, Y., Osaka, H., Mazaki, E., Inoue, I., Montal, M., Hashikawa, T., Shike, T., Fujiwara, T., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b9cebc · Cited by 205
Self-citationClinical spectrum of SCN2A mutations expanding to Ohtahara syndrome
Nakamura, K., Kato, M., Osaka, H., Yamashita, S., Nakagawa, E., Haginoya, K., Tohyama, J., Okuda, M., Wada, T., Shimakawa, S., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a43e57 · Cited by 201
Sodium channelopathies in neurodevelopmental disorders
Meisler, M. H., Hill, S. F., & Yu, W. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-00418-4 · Cited by 210
Sodium Channels, Inherited Epilepsy, and Antiepileptic Drugs
Catterall, W. A. (2014) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140232 · Cited by 202
Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy
Liao, Y., Deprez, L., Maljevic, S., Pitsch, J., Claes, L., Hristova, D., Jordanova, A., Ala-Mello, S., Bellan-Koch, A., Blazevic, D., et al. (2010) · Brain · doi:10.1093/brain/awq057 · Cited by 185
SCN1A duplications and deletions detected in Dravet syndrome: Implications for molecular diagnosis
Marini, C., Scheffer, I. E., Nabbout, R., Mei, D., Cox, K., Dibbens, L. M., McMahon, J. M., Iona, X., Sánchez-Carpintero, R., Elia, M., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02013.x · Cited by 173
Wei, F., Yan, L.-M., Su, T., He, N., Lin, Z.-J., Wang, J., Shi, Y., Yi, Y., & Liao, W. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0134-1 · Cited by 147
Deneault, E., White, S. H., Rodrigues, D. C., Ross, P. J., Faheem, M., Zaslavsky, K., Wang, Z., Alexandrova, R., Pellecchia, G., Wei, W., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.003 · Cited by 145
Epilepsy-Related Voltage-Gated Sodium Channelopathies: A Review
Menezes, L. F. S., Júnior, E. F. S., Tibery, D. V., Carneiro, L. D. A., & Schwartz, E. F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01276 · Cited by 143
Sodium channelopathies of skeletal muscle and brain
Mantegazza, M., Cestèle, S., & Catterall, W. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00025.2020 · Cited by 137
Missense mutation of the sodium channel gene SCN2A causes Dravet syndrome
Shi, X., Yasumoto, S., Nakagawa, E., Fukasawa, T., Uchiya, S., & Hirose, S. (2009) · Brain and Development · doi:10.1016/j.braindev.2009.08.009 · Cited by 131
Genes of Early-Onset Epileptic Encephalopathies: From Genotype to Phenotype
Mastrangelo, M., & Leuzzi, V. (2011) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2011.11.003 · Cited by 129
Kullmann, D. M. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153122 · Cited by 133
The phenotypic spectrum of SCN2A-related epilepsy
Reynolds, C., King, M. D., & Gorman, K. M. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.016 · Cited by 124
Scheffer, I. E., French, J. A., Hirsch, É., Jain, S., Mathern, G. W., Moshé, S. L., Perucca, E., Tomson, T., Wiebe, S., Zhang, Y., et al. (2016) · Epilepsia Open · doi:10.1002/epi4.5 · Cited by 125
Clinical spectrum of SCN2A mutations
Shi, X., Yasumoto, S., Kurahashi, H., Nakagawa, E., Fukasawa, T., Uchiya, S., & Hirose, S. (2011) · Brain and Development · doi:10.1016/j.braindev.2011.09.016 · Cited by 122
Impaired cortico-striatal excitatory transmission triggers epilepsy
Miyamoto, H., Tatsukawa, T., Shimohata, A., Yamagata, T., Suzuki, T., Amano, K., Mazaki, E., Raveau, M., Ogiwara, I., Asaka-Oba, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09954-9 · Cited by 124
Self-citationScalmani, P., Rusconi, R., Armatura, E., Zara, F., AVANZINI, G., Franceschetti, S., & Mantegazza, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2476-06.2006 · Cited by 122
Action Potential Initiation in Neocortical Inhibitory Interneurons
Li, T., Tian, C., Scalmani, P., Frassoni, C., Mantegazza, M., Wang, Y., Yang, M., Wu, S., & Shu, Y. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001944 · Cited by 115
Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice
Ogiwara, I., Miyamoto, H., Tatsukawa, T., Yamagata, T., Nakayama, T., Atapour, N., Miura, E., Mazaki, E., Ernst, S. J., Cao, D., et al. (2018) · Communications Biology · doi:10.1038/s42003-018-0099-2 · Cited by 115
Self-citationGenetic and epigenetic mechanisms of epilepsy: a review
Chen, T., Giri, M., Xia, Z., Subedi, Y. N., & Li, Y. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s142032 · Cited by 111
Wolff, M., Brunklaus, A., & Zuberi, S. M. (2019) · Epilepsia · doi:10.1111/epi.14935 · Cited by 105
Misra, S. N., Kahlig, K. M., & George, A. L. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01619.x · Cited by 104
Meents, J., Bressan, E., Sontag, S., Foerster, A., Hautvast, P. A. I., Rösseler, C., Hampl, M., Schüler, H. M., Goetzke, R., Le, T. K. C., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001511 · Cited by 99
Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia
Schwarz, N., Hahn, A., Bast, T., Müller, S., Löffler, H., Maljevic, S., Gaily, E., Prehl, I., Biskup, S., Joensuu, T., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-015-7984-0 · Cited by 95
Novel SCN1A Mutation in a Proband With Malignant Migrating Partial Seizures of Infancy
Freilich, E. R., Jones, J. M., Gaillard, W. D., Conry, J. A., Tsuchida, T. N., Reyes, C., Dib‐Hajj, S. D., Waxman, S. G., Meisler, M. H., & Pearl, P. L. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.98 · Cited by 93
Genotype phenotype associations across the voltage-gated sodium channel family
Brunklaus, A., Ellis, R., Reavey, E., Semsarian, C., & Zuberi, S. M. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102608 · Cited by 92
Channel, neuronal and clinical function in sodium channelopathies: from genotype to phenotype
Waxman, S. G. (2007) · Nature Neuroscience · doi:10.1038/nn1857 · Cited by 88
Ramírez, A., Vázquez-Sánchez, A. Y., Carrión-Robalino, N., & Camacho, J. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3928714 · Cited by 90
Xu, R., Thomas, E. A., Jenkins, M., Gazina, E. V., Chiu, C., Heron, S. E., Mulley, J. C., Scheffer, I. E., Berkovic, S. F., & Petrou, S. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.03.003 · Cited by 84
Tatsukawa, T., Raveau, M., Ogiwara, I., Hattori, S., Miyamoto, H., Mazaki, E., Itohara, S., Miyakawa, T., Montal, M., & Yamakawa, K. (2019) · Molecular Autism · doi:10.1186/s13229-019-0265-5 · Cited by 87
Self-citationHirose, S. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.12.007 · Cited by 82
Shin, W., Kweon, H., Kang, R., Kim, D., Kim, K., Kang, M., Kim, S. Y., Hwang, S. N., Kim, J. Y., Yang, E., et al. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00145 · Cited by 83
Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy
Madia, F., Striano, P., Gennaro, E., Malacarne, M., Paravidino, R., Biancheri, R., Budetta, M., Cilio, M. R., Gaggero, R., Pierluigi, M., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000238513.70878.54 · Cited by 78
Precision medicine in genetic epilepsies: break of dawn?
Reif, P. S., Tsai, M., Helbig, I., Rosenow, F., & Klein, K. M. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1253476 · Cited by 77
Ji, L., Chauhan, A., Brown, W. T., & Chauhan, V. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.10.008 · Cited by 72
Baasch, A., Hüning, I., Gilissen, C., Klepper, J., Veltman, J. A., Gillessen‐Kaesbach, G., Hoischen, A., & Lohmann, K. (2014) · Epilepsia · doi:10.1111/epi.12554 · Cited by 71
Sodium channel dysfunction in intractable childhood epilepsy with generalized tonic–clonic seizures
Rhodes, T. H., Vanoye, C. G., Ohmori, I., Ogiwara, I., Yamakawa, K., & George, A. L. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.094326 · Cited by 72
Self-citationEpileptogenic Channelopathies: Experimental Models of Human Pathologies
AVANZINI, G., Franceschetti, S., & Mantegazza, M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01067.x · Cited by 70
Ademuwagun, I. A., Rotimi, S. O., Syrbe, S., Ajamma, Y. U., & Adebiyi, E. F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.600050 · Cited by 68
Contribution of voltage‐gated sodium channels to the b‐wave of the mammalian flash electroretinogram
Mojumder, D. K., Sherry, D. M., & Frishman, L. J. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.150755 · Cited by 68
Middleton, S. J., Kneller Emily, M., Chen, S., Ogiwara, I., Montal, M., Yamakawa, K., & McHugh, T. J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0163-8 · Cited by 70
Self-citationPure haploinsufficiency for Dravet syndrome NaV1.1 (SCN1A) sodium channel truncating mutations
Bechi, G., Scalmani, P., Schiavon, E., Rusconi, R., Franceschetti, S., & Mantegazza, M. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03346.x · Cited by 67
Begemann, A., Acuña, M. A., Zweier, M., Vincent, M., Steindl, K., Bachmann‐Gagescu, R., Hackenberg, A., Abela, L., Plecko, B., Kroell-Seger, J., et al. (2019) · Molecular Medicine · doi:10.1186/s10020-019-0073-6 · Cited by 66
Self-citationDe novo SCN2A splice site mutation in a boy with Autism spectrum disorder
Tavassoli, T., Kolevzon, A. L., Wang, A. T., Curchack, J. T., Halpern, D. B., Schwartz, L., Soffes, S., Bush, L., Grodberg, D., Cai, G., et al. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-35 · Cited by 62
Mishra, V., Karumuri, B. K., Gautier, N. M., Liu, R., Hutson, T. N., Vanhoof‐Villalba, S. L., VLACHOS, I. K., Iasemidis, L. D., & Glasscock, E. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx104 · Cited by 61
Voltage-Gated Sodium Channels: Mutations, Channelopathies and Targets
Andavan, G. S. B., & Lemmens‐Gruber, R. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794839133 · Cited by 61
Santos-Rebouças, C. B., Rodrigues, N. F., Jensen, L. R., Kuss, A. W., Ribeiro, M. G., Campos, M., dos Santos, J. M., & Pimentel, M. M. G. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.04.065 · Cited by 59
Bend, E. G., Si, Y. C., Stevenson, D. A., Bayrak‐Toydemir, P., Newcomb, T. M., Jørgensen, E. M., & Swoboda, K. J. (2016) · Neurology · doi:10.1212/wnl.0000000000003095 · Cited by 59
Neonatal Epilepsy Syndromes and Generalized Epilepsy with Febrile Seizures Plus (GEFS+)
Scheffer, I. E., Harkin, L. A., Dibbens, L. M., Mulley, J. C., & Berkovic, S. F. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00358.x · Cited by 59
Andrade, D. M. (2009) · Human Genetics · doi:10.1007/s00439-009-0702-1 · Cited by 59
Yamagata, T., Ogiwara, I., Mazaki, E., Yanagawa, Y., & Yamakawa, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.013 · Cited by 57
Self-citationYe, M., Yang, J., Tian, C., Zhu, Q., Yin, L., Jiang, S., Yang, M., & Shu, Y. (2018) · Scientific Reports · doi:10.1038/s41598-017-17344-8 · Cited by 54
Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation
Carroll, L. S., Woolf, R., Ibrahim, Y., Williams, H. J., Dwyer, S., Walters, J., Kirov, G., O’Donovan, M. C., & Owen, M. J. (2016) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000110 · Cited by 54
The Role of the Persistent Sodium Current in Epilepsy
Wengert, E. R., & Patel, M. K. (2020) · Epiliepsy currents/Epilepsy currents · doi:10.1177/1535759720973978 · Cited by 55
Wu, J., Li, Y., & Jiang, R. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004237 · Cited by 54
Autism spectrum disorder and epileptic encephalopathy: common causes, many questions
Srivastava, S., & Şahin, M. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9202-0 · Cited by 55
Léna, I., & Mantegazza, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-49392-7 · Cited by 57
Wild-type and mutant ferroportins do not form oligomers in transfected cells
Gonçalves, A. S., Muzeau, F., Blaybel, R., Hetet, G., Driss, F., Delaby, C., Canonne‐Hergaux, F., & Beaumont, C. (2006) · Biochemical Journal · doi:10.1042/bj20051682 · Cited by 55
Amiet, C., Gourfinkel‐An, I., Laurent‐Levinson, C., Bodeau, N., Génin, B., Leguern, É., Tordjman, S., & Cohen, D. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-47 · Cited by 54
SCN 2A channelopathies: Mechanisms and models
Hedrich, U. B. S., Lauxmann, S., & Lerche, H. (2019) · Epilepsia · doi:10.1111/epi.14731 · Cited by 54
Brunklaus, A., & Lal, D. (2020) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14519 · Cited by 49
Que, Z., Olivero-Acosta, M. I., Zhang, J., Eaton, M., Tukker, A. M., Chen, X., Wu, J., Xie, J., Xiao, T., Wettschurack, K. W., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0564-21.2021 · Cited by 47
Resurgent and Gating Pore Currents Induced by De Novo SCN2A Epilepsy Mutations
Mason, E. R., Wu, F., Patel, R. R., Xiao, Y., Cannon, S. C., & Cummins, T. (2019) · eNeuro · doi:10.1523/eneuro.0141-19.2019 · Cited by 46
Molecular bases and clinical spectrum of early infantile epileptic encephalopathies
Asher, Y. J. T., & Scaglia, F. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.04.002 · Cited by 45
Kang, J., Shen, W., Lee, M., Gallagher, M. J., & Macdonald, R. L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2320-10.2010 · Cited by 45
Ishii, A., Kanaumi, T., Sohda, M., Misumi, Y., Zhang, B., Kakinuma, N., Haga, Y., Watanabe, K., Takeda, S., Okada, M., et al. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2013.12.005 · Cited by 43
Lauxmann, S., Boutry‐Kryza, N., Rivier, C., Mueller, S., Hedrich, U. B. S., Maljevic, S., Szepetowski, P., Lerche, H., & Lesca, G. (2013) · Epilepsia · doi:10.1111/epi.12241 · Cited by 43
Sodium Channel Mutations and Epilepsy
Catterall, W. A. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0052 · Cited by 43
Kotlar, A., Mercer, K. B., Zwick, M. E., & Mullé, J. G. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.10.008 · Cited by 42
Dutta, U. R., Rao, S. N., Pidugu, V. K., Vineeth, V. S., Bhattacherjee, A., Bhowmik, A. D., Ramaswamy, S. K., Singh, K. G., & Dalal, A. B. (2018) · Genomics · doi:10.1016/j.ygeno.2018.07.005 · Cited by 40
Voltage‐gated sodium channels: Action players with many faces
Koopmann, T. T., Bezzina, C. R., & Wilde, A. A. M. (2006) · Annals of Medicine · doi:10.1080/07853890600969072 · Cited by 40
Relationship of electrophysiological dysfunction and clinical severity inSCN2A-related epilepsies
Lauxmann, S., Verbeek, N. E., Liu, Y., Zaichuk, M., Müller, S., Lemke, J. R., van Kempen, M. J. A., Lerche, H., & Hedrich, U. B. S. (2018) · Human Mutation · doi:10.1002/humu.23619 · Cited by 39
Confirming an expanded spectrum of SCN2A mutations: a case series
Matalon, D. R., Goldberg, E. M., Medne, L., & Marsh, E. D. (2014) · Epileptic Disorders · doi:10.1684/epd.2014.0641 · Cited by 37
Association of genes with phenotype in autism spectrum disorder
Nisar, S., Hashem, S., Bhat, A. A., Syed, N., Yadav, S. K., Azeem, M. W., Shahab Uddin, M. S., Bagga, P., Reddy, R. D., & Haris, M. (2019) · Aging · doi:10.18632/aging.102473 · Cited by 39
Saitoh, M., Ishii, A., Ihara, Y., Hoshino, A., Terashima, H., Kubota, M., Kikuchi, K., Yamanaka, G., Amemiya, K., Hirose, S., et al. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.08.001 · Cited by 35
Novel Genes of Early-Onset Epileptic Encephalopathies: From Genotype to Phenotypes
Mastrangelo, M. (2015) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2015.04.001 · Cited by 35
Acute encephalopathy with a novel point mutation in the SCN2A gene
Kobayashi, K., Ohzono, H., Shinohara, M., Saitoh, M., Ohmori, I., Ohtsuka, Y., & Mizuguchi, M. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.04.016 · Cited by 32
Phenotypes and genotypes in epilepsy with febrile seizures plus
Ito, M., Yamakawa, K., Sugawara, T., Hirose, S., Fukuma, G., & Kaneko, S. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.11.028 · Cited by 32
Self-citation
Metadata
- Authors
- Kamiya, K., Kaneda, M., Sugawara, T., Mazaki, E., Okamura, N., Montal, M., Makita, N., Tanaka, M., Fukushima, K., Fujiwara, T., Inoue, Y., & Yamakawa, K.
- Affiliations
- RIKEN (JP)
- Keio University (JP)
- University of California San Diego (US)
- Hokkaido University (JP)
- RIKEN Center for Brain Science (JP)
- National Epilepsy Center (JP)
- Corresponding author
- Yamakawa, Kazuhiro
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2004-03-17
- Volume
- 24
- Issue
- 11
- Pages
- 2690-2698
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6729532
- OpenAlex
- W2096680774
- Cited by
- 199
- References
- 49
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 1 · 2023: 7 · 2022: 5 · 2021: 10 · 2020: 7 · 2019: 13 · 2018: 10 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 20 · 2013: 11 · 2012: 10
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Keio University
- National Institutes of Health
- RIKEN
- National Institute of General Medical Sciences (GM-49711, R01GM049711)
- RIKEN Brain Science Institute
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- SCN2A, nonsense mutation, drug-resistant epilepsy, intellectual disability, Dravet syndrome, de novo mutations, dominant negative effect, haploinsufficiency, voltage-gated sodium channels, voltage-dependent inactivation, subcellular localization, cytoskeletal interactions, focal epilepsy
- MeSH terms
- Adult, Autistic Disorder, Cell Line, DNA Mutational Analysis, Electroencephalography, Epilepsy, Female, Genes, Dominant, Humans, Hyperkinesis, Kidney, Intellectual Disability, Nerve Tissue Proteins, Pedigree, Transfection, Sodium Channels, Gene Expression, Codon, Nonsense, Patch-Clamp Techniques, Protein Subunits, NAV1.2 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review